New Blood Test Improves Early Pancreatic Cancer Detection by 27%
An experimental test detects early-stage pancreatic cancer more effectively than current tests via a combination of two sugar biomarkers.
Category: Pancreatic
Pancreatic
Latest
Pancreatic
Latest
Biomarkers Show Promise for Finding Pancreatic Cancer Risk Early
A research team identified biomarkers that could help distinguish whether cysts on the pancreas will develop into cancer or remain benign.
Pancreatic
Latest
Personalis & BC Cancer Assess Benefits of ctDNA for Colorectal, Pancreatic Cancers
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Study: PTX3 Biomarker Could Aid in Pancreatic Cancer Diagnosis
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer.
Read More
Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching by Nearly 300% with GenomOncology
PanCAN has chosen to upgrade to GenomOncology’s Precision Decision to further enhance the free clinical trial matching services it offers to pancreatic cancer patients.
Read More
AI-based Tool Predicts Genomic Subtypes of Pancreatic Cancer From Histology Slides
The AI-based tool for predicting genomic subtypes of PDAC can be used in clinical practice worldwide for patient stratification.
Read More
‘Electronic Nose’ Accurately Sniffs Out Hard-to-Detect Cancers
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish cancer cells with up to 95% accuracy.
Read More
Sysmex Inostics’ Liquid Biopsy Testing Aids Pancreatic Cancer Management
cfDNA-based liquid biopsy analysis of KRAS mutations using OncoBEAM technology can assist in the prognosis determination and management of PDAC patients.
Read More
Merus, Caris Life Sciences Collaborate to Detect NRG1 Fusions in Cancer Patients
Caris will provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial.
Read More
Blood Test May Help Doctors Catch Pancreatic Cancer Early
Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging of pancreatic cancer.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More
Interventional Study to Evaluate Multicancer Early Detection Test
The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.
Read More
Cancer Detection and Liquid Biopsy
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read More
Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MoreUS Preventive Services Task Force Issues Final Recommendation on BRCA-Related Cancer Prevention
Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.
Read More
BRACAnalysis CDx Identifies Patients with Metastatic Pancreatic Cancer Who Benefit from Treatment with Lynparza
Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.
Read More
Biodesix and Immodulon Announce Research Collaboration for Pancreatic Cancer Treatment
The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.
Read More
Researchers Advance Method for Characterizing Pancreatic Cancer
An Okayama University study reports the utility of identifying PD-L1 status at the time of diagnosing pancreatic cancer and demonstrates that fine-needle aspiration can be useful in facilitating such diagnoses.
Read More